Structure–Activity Relationship (SAR) Optimization of 6-(Indol-2-yl)pyridine-3-sulfonamides: Identification of Potent, Selective, and Orally Bioavailable Small Molecules Targeting Hepatitis C (HCV) NS4B | Journal of Medicinal Chemistry
nCoV2019.live Global Dashboard - ICAP at Columbia University
FastQ RhD fetal - for sensible rhesus prophylaxis - Home